Based on the results of many previous studies, strategies such as removing insoluble tau through antibody therapy and the modification of the molecular properties of tau, including post-translational modifications, have been considered promising for the treatment of tauopathy.17,18 However, despite many potential agents reaching advanced clinical trial stages, most approaches have not been successful. Here, MAPT is linked to tauopathy.